27. Gosset P, Pichavant M, Faveeuw C, Bureau F, Tonnel AB, Trottein F. Prostaglandin D2 affects the differentiation and func- tions of human dendritic cells: impact on the T cell response. Eur J Immunol 2005;35:1491-1500. 28. Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 2004;316:1009-1014. 29. Hirano Y, Shichijo M, Deguchi M, et al. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced pro- duction of MCP-1 and IL-8 in human monocytic THP-1 cells. Eur J Pharmacol 2007;560:81-88. 30. Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287:2013-2017. 31. Arimura A, Yasui K, Kishino J, et al. Prevention of allergic inflam- mation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 2001;298:411-419. 32. Zhu G, Vestbo J, Lenney W, et al. Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun 2007;8:398-403. 33. Cosmi L, Annunziato F, Iwasaki M, et al. CRTH2 is the most reli- able marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 2000;30:2972-2979. 34. Nagata K, Hirai H, Tanaka K, et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999;459:195- 199. 35. Gosset P, Bureau F, Angeli V, et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: conse- quence on the polarization of naive Th cells. J Immunol 2003;170:4943-4952. 36. Gazi L, Gyles S, Rose J, et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activa- tion of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 2005;75:153-167. 37. Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxy- delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 2002;168:3563-3569. 38. Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003;170:4752- 4758. 39. Schmidt G, Goehring UM, Schirmer J, et al. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect Immun 2001;69:7663- 7670. 40.Bohm E, Sturm GJ, Weiglhofer I, et al. 11-Dehydro-thromboxane Arima M and Fukuda T. Role of prostaglandin D2 in asthma 17 B2, a stable thromboxane metabolite, is a full agonist of chemoat- tractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004;279:7663-7670. 41. Sugimoto H, Shichijo M, Iino T, et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003;305:347-352. 42. Shichijo M, Sugimoto H, Nagao K, et al. Chemoattractant recep- tor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. J Pharmacol Exp Ther 2003;307:518-525. 43.Uller L, Mathiesen JM, Alenmyr L, et al. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007; 8:16-25. 44.Narita S, Asakura K, Kataura A. Effects of thromboxane A2 recep- tor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996;109:161-166. 45. Nagai H, Takeda H, Yamaguchi S, Tanaka H, Matsuo A, Inagaki N. The effect of a thromboxane A2 receptor antagonist BAY-u- 3405 on experimental allergic reactions. Prostaglandins 1995;50:75-87. 46.Kabashima K, Narumiya S. The DP receptor, allergic inflamma- tion and asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:187-194. 47. Nagata K, Hirai H. The second PGD(2) receptor CRTH2: struc- ture, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003;69:169-177. 48.Nantel F, Fong C, Lamontagne S, et al. Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 2004;73:87-101. 49.Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cel- lular migration by DP and CRTH2 receptors. J Bone Miner Res 2005;20:672-681. 50. Hirai H, Abe H, Tanaka K, et al. Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. Biochem Biophys Res Commun 2003;307:797-802. 51. Xue L, Gyles SL, Wettey FR, et al. Prostaglandin D2 causes pref- erential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005;175:6531-6536. 52. Clarke DL, Belvisi MG, Smith SJ, et al. Prostanoid receptor expression by human airway smooth muscle cells and regulation